IL33 and systemic sclerosis: In the last decade, studies have identified IL-33 as a potential culprit in numerous inflammatory diseases such as asthma [56], inflammatory bowel disease (IBD) [57], rheumatoid arthritis [58], systemic sclerosis [59] and systemic lupus erythematosus (SLE) [60].